Literature DB >> 7824139

Visual field loss in senile dementia of the Alzheimer's type.

G L Trick1, L R Trick, P Morris, M Wolf.   

Abstract

BACKGROUND: Visual performance is impaired in patients with senile dementia of the Alzheimer's type (SDAT). We investigated the visual field topography of these deficits.
METHODS: Humphrey automated perimetry (Program 30-2) was used to measure differential luminance sensitivity within the central 60 degrees of the visual field in SDAT patients (n = 61) and in visually and cognitively normal volunteer subjects of similar age (n = 61). Twenty-three SDAT patients were retested 18 months after the original examination.
RESULTS: Reliable visual fields (by manufacturer's criteria) were obtained in 72.1% (44/61) of the control subjects and 55.7% (34/61) of the SDAT group. In the SDAT group, differential luminance sensitivity was significantly reduced relative to the control group. Visual sensitivity was reduced throughout the visual field, but deficits were most pronounced in the inferior visual field, where they presented most commonly as arcuate defects. Patients with more severe dementia exhibited greater reductions in visual sensitivity. On follow-up, 14 of 23 SDAT patients exhibited progression of visual field loss, whereas only two of 23 patients exhibited a regression of the visual field loss.
CONCLUSIONS: Although automated perimetry requires considerable patient cooperation, many patients with SDAT can produce reliable visual field results. These patients exhibit significant reductions in global sensitivity. Visual field loss in SDAT is most pronounced in the inferonasal and inferotemporal arcuate regions of the visual field but also involves the central field.

Entities:  

Mesh:

Year:  1995        PMID: 7824139     DOI: 10.1212/wnl.45.1.68

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  52 in total

1.  Visual evoked potentials to pattern, motion and cognitive stimuli in Alzheimer's disease.

Authors:  Z Kubová; J Kremlácek; M Valis; J Langrová; J Szanyi; F Vít; M Kuba
Journal:  Doc Ophthalmol       Date:  2010-06-04       Impact factor: 2.379

2.  Optical coherence tomography as a potential readout in clinical trials.

Authors:  Benjamin M Greenberg; Elliot Frohman
Journal:  Ther Adv Neurol Disord       Date:  2010-05       Impact factor: 6.570

3.  Optical coherence tomography assessed retinal nerve fiber layer thickness in patients with Alzheimer's disease: a meta-analysis.

Authors:  Xue-Fei He; Yi-Ting Liu; Cheng Peng; Fan Zhang; Shi Zhuang; Jin-Song Zhang
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

4.  Ocular changes in TgF344-AD rat model of Alzheimer's disease.

Authors:  Yuchun Tsai; Bin Lu; Alexander V Ljubimov; Sergey Girman; Fred N Ross-Cisneros; Alfredo A Sadun; Clive N Svendsen; Robert M Cohen; Shaomei Wang
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-29       Impact factor: 4.799

Review 5.  [Retinal imaging of the macula and optic disc in neurodegenerative diseases].

Authors:  G N Turski; S Schmitz-Valckenberg; F G Holz; R P Finger
Journal:  Ophthalmologe       Date:  2017-02       Impact factor: 1.059

6.  Retinal alterations in mild cognitive impairment and Alzheimer's disease: an optical coherence tomography study.

Authors:  Francisco J Ascaso; Nancy Cruz; Pedro J Modrego; Raul Lopez-Anton; Javier Santabárbara; Luis F Pascual; Antonio Lobo; José A Cristóbal
Journal:  J Neurol       Date:  2014-05-21       Impact factor: 4.849

7.  Dysfunction of the magnocellular stream in Alzheimer's disease evaluated by pattern electroretinograms and visual evoked potentials.

Authors:  F Sartucci; D Borghetti; T Bocci; L Murri; P Orsini; V Porciatti; N Origlia; L Domenici
Journal:  Brain Res Bull       Date:  2010-04-10       Impact factor: 4.077

8.  Hemianopic line bisection error in a patient with Alzheimer's disease.

Authors:  Heeyoung Kang; Soo-Kyoung Kim; Ki-Jong Park; Nack-Cheon Choi; Oh-Young Kwon; Byeong Hoon Lim
Journal:  Neurol Sci       Date:  2016-11-28       Impact factor: 3.307

9.  Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease.

Authors:  Yosef Koronyo; David Biggs; Ernesto Barron; David S Boyer; Joel A Pearlman; William J Au; Shawn J Kile; Austin Blanco; Dieu-Trang Fuchs; Adeel Ashfaq; Sally Frautschy; Gregory M Cole; Carol A Miller; David R Hinton; Steven R Verdooner; Keith L Black; Maya Koronyo-Hamaoui
Journal:  JCI Insight       Date:  2017-08-17

10.  Homonymous Hemianopsia Due to Posterior Cortical Atrophy.

Authors:  Francesco Pellegrini; Andrew G Lee; Pietro Zucchetta
Journal:  Neuroophthalmology       Date:  2017-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.